Competition And Pricing PressureThe company is seeing increased generic competition for Rynaxypyr in China, India, Eastern Europe and South America, pressuring both pricing and volumes.
Market UncertaintyThere is much uncertainty on 2026 due to the flux of Chinese generics, even if FMC makes progress with new AIs.
Sales And Earnings ImpactA headwind from US tariffs on Canadian imports is expected to impact FMC's sales and earnings, with each 1% hit to US farm profits potentially cutting FMC sales by $3.8-5.8m.